Olanzapine ER by Teva Pharmaceutical Industries for Schizophrenia: Likelihood of Approval
Olanzapine ER is under clinical development by Teva Pharmaceutical Industries and currently in Phase III for Schizophrenia.
Olanzapine ER is under clinical development by Teva Pharmaceutical Industries and currently in Phase III for Schizophrenia.
What's Your Reaction?
